The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis

LOTZER, K; FUNK, C; HABENICHT, A

doi:10.1016/j.bbalip.2005.07.001

Cited by 108Atherosclerosis and Cardiovascular DiseasesEicosanoids and Hypertension PharmacologyInflammatory mediators and NSAID effects

The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis

LOTZER, K, FUNK, C, HABENICHT, A·2005·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

DOI 10.1016/j.bbalip.2005.07.001

Open this paper in CoChat — free account

Abstract

Leukotrienes (LTs) are powerful inflammatory lipid mediators derived from the 5-lipoxygenase (5-LO) cascade of arachidonic acid. Recent clinical, population genetic, cell biological, and mouse studies indicate participation of the 5-LO pathway in atherogenesis and arterial wall remodeling. 5-LO is expressed by leukocytes including blood monocytes, tissue macrophages, dendritic cells, neutrophils, and mast cells. LTB4 and the cysteinyl LTs LTC4, LTD4, and LTE4, act through two BLT and two cysLT receptors that are differentially expressed on hematopoietic and arterial wall cells. The precise roles of LTs or the LT receptors in cardiovascular physiology remain largely to be explored. In this review, we will discuss what is currently known about the 5-LO atherosclerosis connection. We will attempt to propose strategies to further explore potential links between the 5-LO pathway and blood vessel physiology and disease progression.

Integrity signals

Registry

Crossref · 10.1016/j.bbalip.2005.07.001

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Although NOX4 activity has been shown to reduce fibrosis in atherosclerosis, it can also promote fibrosis, particularly in the lung, but also in kidney and other tissues.
“In a final note, it should be also considered that although NOX4 activity has been shown to reduce fibrosis in atherosclerosis (230), it can also promote fibrosis, particularly in the lung, but also in kidney and other tissues (110, 201, 416, 596, 820).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [596]

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817 · see citing works
Self-citation
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. O. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,858 · see citing works
Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.
Dahlén, S., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019 · see citing works
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971 · see citing works
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O’Neill, G. P., Liu, Q., Im, D., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965 · see citing works
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
Helgadóttir, A., Manolescu, A. R., Þorleifsson, G., Grétarsdóttir, S., Jonsdottir, H., Þorsteinsdóttir, U., Samani, N. J., Gudmundsson, G. H., Grant, S. F. A., Þorgeirsson, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1311 · Cited by 923 · see citing works
Characterization of the Human Cysteinyl Leukotriene 2 Receptor
Heise, C. E., O’Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003490200 · Cited by 660 · see citing works
Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis
Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025079 · Cited by 614 · see citing works
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
Drazen, J. M., Yandava, C., Dubé, L. M., Szczerbak, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N. J., Silverman, E. S., Katz, D. A., et al. (1999) · Nature Genetics · doi:10.1038/9680 · Cited by 561 · see citing works
A Second Leukotriene B4 Receptor, Blt2
Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.421 · Cited by 540 · see citing works
Mouse Models of Abdominal Aortic Aneurysms
Daugherty, A., & Cassis, L. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118013.72016.ea · Cited by 489 · see citing works
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 457 · see citing works
Self-citation
The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes
Robbiani, D. F., Finch, R. A., Jäger, D., Müller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00179-3 · Cited by 455 · see citing works
Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422 · see citing works
Self-citation
Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment
Tager, A. M., Bromley, S. K., Medoff, B. D., Islam, S. A., Bercury, S. D., Friedrich, E. B., Carafone, A. D., Gerszten, R. E., & Luster, A. D. (2003) · Nature Immunology · doi:10.1038/ni970 · Cited by 415 · see citing works
Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene
Chen, X.-S., Shelter, J. R., Johnson, E. N., & Funk, C. D. (1994) · Nature · doi:10.1038/372179a0 · Cited by 414 · see citing works
Self-citation
Arterial Remodeling
Ward, M. R., Pasterkamp, G., Yeung, A. C., & Borst, C. (2000) · Circulation · doi:10.1161/01.cir.102.10.1186 · Cited by 378 · see citing works
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
Zhao, L., Moos, M. P. W., Gräbner, R., Pédrono, F., Fan, J., Kaiser, B., John, N. F. S., Schmidt, S., Spanbroek, R., Lötzer, K., et al. (2004) · Nature Medicine · doi:10.1038/nm1099 · Cited by 353 · see citing works
Self-citation
Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues
Goodarzi, K., Goodarzi, M., Tager, A. M., Luster, A. D., & von Andrian, U. H. (2003) · Nature Immunology · doi:10.1038/ni972 · Cited by 348 · see citing works
Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells.
Huang, A. J. Y., Manning, J. E., Bandak, T. M., Ratau, M. C., Hanser, K. R., & Silverstein, S. C. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.120.6.1371 · Cited by 339 · see citing works
Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.
In, K. H., Asano, K., Beier, D. R., Grobholz, J. K., Finn, P. W., Silverman, E. K., Silverman, E. S., Collins, T., Fischer, A. R., Keith, T. P., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119241 · Cited by 334 · see citing works
Leukotriene B4 in inflammation.
Ford‐Hutchinson, A. W. (1990) · PubMed · Cited by 298 · see citing works
Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils.
McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.7.2204 · Cited by 283 · see citing works
Mast cell–dependent migration of effector CD8+ T cells through production of leukotriene B4
Ott, V. L., Cambier, J. C., Kappler, J. W., Marrack, P., & Swanson, B. J. (2003) · Nature Immunology · doi:10.1038/ni971 · Cited by 280 · see citing works
Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice
Aiello, R. J., Bourassa, P.-A. K., Lindsey, S., Weng, W., Freeman, A., & Showell, H. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.105593 · Cited by 247 · see citing works
Effects of a 5-Lipoxygenase–Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction
Hakonarson, H. H., Thorvaldsson, S., Helgadóttir, A., Gudbjartsson, D. F., Zink, F., Andrésdóttir, M. B., Manolescu, A. R., Arnar, D. O., Andersen, K. K., Sigurðsson, A. F., et al. (2005) · JAMA · doi:10.1001/jama.293.18.2245 · Cited by 237 · see citing works
Association between the Gene Encoding 5-Lipoxygenase–Activating Protein and Stroke Replicated in a Scottish Population
Helgadóttir, A., Grétarsdóttir, S., Clair, D. S., Manolescu, A. R., Cheung, J., Þorleifsson, G., Pasdar, A., Grant, S. F. A., Whalley, L. J., Hakonarson, H. H., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/428066 · Cited by 231 · see citing works
Leukotriene D 4 : a Potent Coronary Artery Vasoconstrictor Associated with Impaired Ventricular Contraction
Michelassi, F., Landa, L., Hill, R. D., Lowenstein, E., Watkins, W. D., Petkau, A. J., & Zapol, W. M. (1982) · Science · doi:10.1126/science.6808665 · Cited by 217 · see citing works
Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey
SMEDEGÅRD, G., Hedqvist, P., Dahlén, S., Revenäs, B., Hammarström, S., & Samuelsson, B. O. (1982) · Nature · doi:10.1038/295327a0 · Cited by 202 · see citing works
ALOX5AP Gene and the PDE4D Gene in a Central European Population of Stroke Patients
Lõhmussaar, E., Gschwendtner, A., Mueller, J. C., Org, T., Wichmann, E., Hamann, G. F., Meitinger, T., & Dichgans, M. (2005) · Stroke · doi:10.1161/01.str.0000157587.59821.87 · Cited by 183 · see citing works
Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro.
Burke, J. A., Levi, R., Guo, Z. G., & Corey, E. J. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33042-9 · Cited by 181 · see citing works
From Asthma to Atherosclerosis — 5-Lipoxygenase, Leukotrienes, and Inflammation
Caterina, R. D., & Zampolli, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038190 · Cited by 173 · see citing works
Targeted Gene Disruption Reveals the Role of the Cysteinyl Leukotriene 2 Receptor in Increased Vascular Permeability and in Bleomycin-induced Pulmonary Fibrosis in Mice
Beller, T. C., Maekawa, A., Friend, D. S., Austen, K. F., & Kanaoka, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407057200 · Cited by 155 · see citing works
Leukotriene B4Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes
Huang, L., Zhao, A., Wong, F., Ayala, J. M., Struthers, M. D., Ujjainwalla, F., Wright, S. D., Springer, M. S., Evans, J. F., & Cui, J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000140063.06341.09 · Cited by 143 · see citing works
Egr-1 and Sp1 Interact Functionally with the 5-Lipoxygenase Promoter and Its Naturally Occurring Mutants
Silverman, E. S., Du, J., Sanctis, G. T. D., Rådmark, O., Samuelsson, B. O., Drazen, J. M., & Collins, T. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.2.3154 · Cited by 123 · see citing works
Differential Leukotriene Constrictor Responses in Human Atherosclerotic Coronary Arteries
Allen, S. P., Dashwood, M. R., Morrison, K. J. M., & Yacoub, M. H. (1998) · Circulation · doi:10.1161/01.cir.97.24.2406 · Cited by 112 · see citing works
5-Lipoxygenase and atherosclerosis
Mehrabian, M., & Allayee, H. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00005 · Cited by 111 · see citing works
Differential Leukotriene Receptor Expression and Calcium Responses in Endothelial Cells and Macrophages Indicate 5-Lipoxygenase–Dependent Circuits of Inflammation and Atherogenesis
Lötzer, K., Spanbroek, R., Hildner, M., Urbach, A., Heller, R., Bretschneider, E., Galczenski, H., Evans, J. F., & Habenicht, A. J. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082690.23131.cb · Cited by 106 · see citing works
Self-citation
Peptido-Leukotrienes Are Potent Agonists of von Willebrand Factor Secretion and P-Selectin Surface Expression in Human Umbilical Vein Endothelial Cells
Datta, Y. H., Romano, M., Jacobson, B. C., Golan, D. E., Serhan, C. N., & Ewenstein, B. M. (1995) · Circulation · doi:10.1161/01.cir.92.11.3304 · Cited by 102 · see citing works
Directed Vascular Expression of Human Cysteinyl Leukotriene 2 Receptor Modulates Endothelial Permeability and Systemic Blood Pressure
Hui, Y., Cheng, Y., Smalera, I., Jian, W., Goldhahn, L., FitzGerald, G. A., & Funk, C. D. (2004) · Circulation · doi:10.1161/01.cir.0000147775.50954.aa · Cited by 99 · see citing works
Self-citation
Genetic Locus in Mice That Blocks Development of Atherosclerosis Despite Extreme Hyperlipidemia
Mehrabian, M., Wong, J., Wang, X., Jiang, Z., Shi, W., Fogelman, A. M., & Lusis, A. J. (2001) · Circulation Research · doi:10.1161/hh1401.093458 · Cited by 84 · see citing works
Cysteinyl Leukotrienes Induce P-Selectin Expression in Human Endothelial Cells via a Non-Cys LT1 Receptor-Mediated Mechanism
Pedersen, K. E., Bochner, B. S., & Undem, B. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36665-0 · Cited by 82 · see citing works
Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells
Palmberg, L., Claesson, H., & Thyberg, J. (1987) · Journal of Cell Science · doi:10.1242/jcs.88.2.151 · Cited by 82 · see citing works
Mechanisms of Leukotriene B4–Triggered Monocyte Adhesion
Friedrich, E. B., Tager, A. M., Liu, E. H., Pettersson, A., Owman, C., Munn, L. L., Luster, A. D., & Gerszten, R. E. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000092941.77774.3c · Cited by 73 · see citing works
Cysteinyl Leukotriene D4 Induced Vascular Smooth Muscle Cell Proliferation: A Possible Role in Myointimal Hyperplasia
Porreca, E., Febbo, C. D., Sciullo, A. D., Angelucci, D., Nasuti, M., Vitullo, P., Reale, M., Conti, P., Cuccurullo, F., & Poggi, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650530 · Cited by 51 · see citing works
Genetic Variations in the 5-Lipoxygenase Core Promoter: Description and Functional Implications
Silverman, E. S., & Drazen, J. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-16 · Cited by 46 · see citing works
Effects of leukotriene C4 and D4, histamine and bradykinin on cytosolic calcium concentrations and adhesiveness of endothelial cells and neutrophils
Heimbürger, M., & Palmblad, J. E. W. (1996) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1996.tb08302.x · Cited by 45 · see citing works
Effects of leukotrienes C4 and D4 on human isolated saphenous veins.
Allen, S. P., Chester, A. H., Piper, P. J., Sampson, A. P., Akl, E. S., & Yacoub, M. H. (1992) · PubMed Central · Cited by 34 · see citing works
Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice
Goulet, J. L., Griffiths, R. C., Ruiz, P., Mannon, R. B., Flannery, P., Platt, J. L., Koller, B. H., & Coffman, T. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6631 · Cited by 31 · see citing works
Endothelial-dependent relaxation induced by leukotrienes C4, D4, and E4 in isolated canine arteries.
Secrest, R. J., & Chapnick, B. M. (1988) · Circulation Research · doi:10.1161/01.res.62.5.983 · Cited by 14 · see citing works

Flagged first, then by citations

Sorted by citations

Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Zheng, W., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,467 · see citing works
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769 · see citing works
Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function.
Fialkow, L., Wang, Y.-C., & Downey, G. (2007) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2006.09.030 · Cited by 722 · see citing works
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works
Inflammatory networks in ageing, age-related diseases and longevity
Vasto, S., Candore, G., Balistreri, C. R., Caruso, M., Colonna‐Romano, G., Grimaldi, M. P., Listı̀, F., Nuzzo, D., Lio, D., & Caruso, C. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.015 · Cited by 481 · see citing works
5-Lipoxygenase: regulation of expression and enzyme activity
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. O. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.002 · Cited by 468 · see citing works
Monocyte recruitment and foam cell formation in atherosclerosis
Bobryshev, Y. V. (2005) · Micron · doi:10.1016/j.micron.2005.10.007 · Cited by 370 · see citing works
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 331 · see citing works
Self-citation
CVD and Oxidative Stress
Cervantes-Gracia, K., Llanas-Cornejo, D., & Husi, H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020022 · Cited by 314 · see citing works
Anti-inflammatory therapeutics for the treatment of atherosclerosis
Charo, I. F., & Taub, R. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3444 · Cited by 309 · see citing works
Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease
Zhou, Y., Khan, H. Z., Xiao, J., & Cheang, W. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112029 · Cited by 196 · see citing works
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
Poeckel, D., & Funk, C. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq016 · Cited by 185 · see citing works
Self-citation
International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions
Bäck, M., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004184 · Cited by 151 · see citing works
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
Cronstein, B. N., & Sunkureddi, P. R. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827d8790 · Cited by 145 · see citing works
The effects of dietary flavonoids on the regulation of redox inflammatory networks
Izzi, V. (2012) · Frontiers in bioscience · doi:10.2741/4061 · Cited by 133 · see citing works
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke
Capra, V., Bäck, M., Barbieri, S. S., Camera, M., Tremoli, E., & Rovati, G. E. (2012) · Medicinal Research Reviews · doi:10.1002/med.21251 · Cited by 115 · see citing works
Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A 4 production
Rakonjac, M., Fischer, L., Provost, P., Werz, O., Steinhilber, D., Samuelsson, B. O., & Rådmark, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605150103 · Cited by 106 · see citing works
Leukotrienes Are Essential for the Control of Leishmania amazonensis Infection and Contribute to Strain Variation in Susceptibility
Serezani, C. H., Perrela, J. H., Russo, M., Peters-Golden, M. L., & Jancar, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3201 · Cited by 99 · see citing works
Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells
Uzonyi, B., Lötzer, K., Jahn, S., Krämer, C., Hildner, M., Bretschneider, E., Radke, D., Beer, M., Vollandt, R., Evans, J. F., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601223103 · Cited by 98 · see citing works
Self-citation
Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies
Rai, G., Joshi, N., Jung, J. E., Liu, Y., Schultz, L., Yasgar, A., Perry, S., Diaz, G., Zhang, Q., Kenyon, V. A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401915r · Cited by 97 · see citing works
Phosphoinositide and Inositolpolyphosphate Signalling in Defense Responses of Arabidopsis thaliana Challenged by Mechanical Wounding
Mosblech, A., König, S., Stenzel, I., Grzeganek, P., Feußner, I., & Heilmann, I. (2008) · Molecular Plant · doi:10.1093/mp/ssm028 · Cited by 83 · see citing works
Peripheral arterial occlusive disease: Global gene expression analyses suggest a major role for immune and inflammatory responses
Fu, S., Zhao, H., Shi, J., Abzhanov, A., Crawford, K. D., Lucila Ohno-machado, A., Zhou, J., Du, Y., Kuo, W. P., Zhang, J., et al. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-369 · Cited by 81 · see citing works
Occurrence of azo food dyes and their effects on cellular inflammatory responses
Leo, L., Loong, C., Ho, X. L., Raman, M. F. B., Suan, M. Y. T., & Loke, W. M. (2017) · Nutrition · doi:10.1016/j.nut.2017.08.010 · Cited by 79 · see citing works
Leukotrienes: Mediators that have been typecast as villains
Flamand, N., Mancuso, P., Serezani, C. H., & Brock, T. G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7228-2 · Cited by 70 · see citing works
Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury
Adhikari, N., Charles, N. J., Lehmann, U., & Hall, J. L. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0081-1 · Cited by 66 · see citing works
mPGES-1 and ALOX5/-15 in tumor-associated macrophages
Weigert, A., Strack, E., Snodgrass, R. G., & Brüne, B. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9731-3 · Cited by 62 · see citing works
Lipoxygenase Pathways as Mediators of Early Inflammatory Events in Atherosclerosis
Funk, C. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222960.43792.ff · Cited by 62 · see citing works
Self-citation
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field
Hoxha, M., Rovati, G. E., & Bueno‐Cavanillas, A. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2242-2 · Cited by 60 · see citing works
Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease
Assimes, T. L., Knowles, J. W., Priest, J. R., Basu, A., Volcik, K. A., Southwick, A. M., Tabor, H. K., Hartiala, J., Allayee, H., Grove, M. L., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0489-5 · Cited by 60 · see citing works
Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
Riccioni, G., Zanasi, A., Vitulano, N., Mancini, B., & D’Orazio, N. (2009) · Mediators of Inflammation · doi:10.1155/2009/737282 · Cited by 58 · see citing works
Cyclooxygenase- and lipoxygenase-mediated DNA damage
Speed, N., & Blair, I. A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9298-8 · Cited by 58 · see citing works
Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?
Yedgar, S., Krimsky, M., Cohen, Y., & Flower, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.07.005 · Cited by 55 · see citing works
Hypertensive Pressure Mechanosensing Alone Triggers Lipid Droplet Accumulation and Transdifferentiation of Vascular Smooth Muscle Cells to Foam Cells
Swiatlowska, P., Tipping, W. J., Marhuenda, E., Severi, P., Fomin, V., Yang, Z., Xiao, Q., Graham, D., Shanahan, C. M., & Iskratsch, T. (2023) · Advanced Science · doi:10.1002/advs.202308686 · Cited by 52 · see citing works
Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice
Zhou, Y., Crichton, I., Tang, S. Y., Hui, Y., Ricciotti, E., Levin, M. D., Lawson, J. A., Puré, E., & FitzGerald, G. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115313109 · Cited by 52 · see citing works
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension
Sacerdoti, D., Pesce, P., Pascoli, M. D., Brocco, S., Cecchetto, L., & Bolognesi, M. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.05.008 · Cited by 50 · see citing works
Cysteinyl leukotriene 2 receptor‐mediated vascular permeability via transendothelial vesicle transport
Moos, M. P. W., Mewburn, J. D., Kan, F. W. K., Ishii, S., Abe, M., Sakimura, K., Noguchi, K., Shimizu, T., & Funk, C. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-113274 · Cited by 50 · see citing works
Self-citation
Human Lipoxygenase Pathway Gene Variation and Association with Markers of Subclinical Atherosclerosis in the Diabetes Heart Study
Burdon, K. P., Rudock, M. E., Lehtinen, A. B., Langefeld, C. D., Bowden, D. W., Register, T. C., Liu, Y., Freedman, B. I., Carr, J. J., Hedrick, C. C., et al. (2010) · Mediators of Inflammation · doi:10.1155/2010/170153 · Cited by 46 · see citing works
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study
Girelli, D., Martinelli, N., Trabetti, E., Olivieri, O., Cavallari, U., Malerba, G., Busti, F., Friso, S., Pizzolo, F., Pignatti, P. F., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201854 · Cited by 43 · see citing works
Arachidonic Acid Metabolites in the Cardiovascular System: The Role of Lipoxygenase Isoforms in Atherogenesis With Particular Emphasis on Vascular Remodeling
Kühn, H., Chaitidis, P., Roffeis, J., & Walther, M. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318159f177 · Cited by 43 · see citing works
Oxylipin formation in Nostoc punctiforme (PCC73102)
Lang, I., & Feußner, I. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.02.028 · Cited by 42 · see citing works
Lipidic last breath of life in patients with alcoholic liver disease
Raszeja‐Wyszomirska, J., Safranow, K., Milkiewicz, M., Milkiewicz, P., Szynkowska, A., & Stachowska, E. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.06.001 · Cited by 41 · see citing works
Novel quinolinone–pyrazoline hybrids: synthesis and evaluation of antioxidant and lipoxygenase inhibitory activity
Kostopoulou, I., Diassakou, A., Kavetsou, E., Kritsi, E., Zoumpoulakis, P. G., Pontiki, E. A., Hadjipavlou‐Litina, D., & Detsi, A. (2020) · Molecular Diversity · doi:10.1007/s11030-020-10045-x · Cited by 40 · see citing works
Role of Sp1 in atherosclerosis
Jiang, J.-F., Zhou, Z., Liu, Y.-Z., Wu, L., Nie, B.-B., Huang, L., & Zhang, C. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07516-9 · Cited by 37 · see citing works
Targeted Chiral Analysis of Bioactive Arachidonic Acid Metabolites Using Liquid-Chromatography-Mass Spectrometry
Mesaros, C., & Blair, I. A. (2012) · Metabolites · doi:10.3390/metabo2020337 · Cited by 37 · see citing works
ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation
Stephensen, C. B., Armstrong, P., Newman, J. W. I., Pedersen, T. L., Legault, J., Schuster, G. U., Kelley, D. S., Vikman, S., Hartiala, J., Nassir, R., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.p012864 · Cited by 37 · see citing works
Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice
Cao, R. Y., Adams, M. A., Habenicht, A. J. R., & Funk, C. D. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.03.005 · Cited by 35 · see citing works
Self-citation
Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems
Lee, S. H., & Blair, I. A. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.7.401 · Cited by 33 · see citing works
Discovery of Boolean metabolic networks: integer linear programming based approach
Qiu, Y., Jiang, H., Ching, W., & Cheng, X. (2018) · BMC Systems Biology · doi:10.1186/s12918-018-0528-3 · Cited by 32 · see citing works
4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase
Yun, M. R., Im, D., Lee, S. J., Park, H. M., Bae, S. S., Lee, W. S., & Kim, C. D. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.12.013 · Cited by 31 · see citing works
Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis
Lubrano, V., Ndreu, R., & Balzan, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021637 · Cited by 30 · see citing works
Plant sterol-enriched soy milk consumption modulates 5-lipoxygenase, 12-lipoxygenase, and myeloperoxidase activities in healthy adults – a randomized-controlled trial
Ho, X. L., Liu, J. J. H., & Loke, W. M. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1252839 · Cited by 30 · see citing works
Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice
Uz, T., Dimitrijević, N., Imbesi, M., Manev, H., & Manev, R. M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.041 · Cited by 30 · see citing works
IFN-γ Induces Cysteinyl Leukotriene Receptor 2 Expression and Enhances the Responsiveness of Human Endothelial Cells to Cysteinyl Leukotrienes
Woszczek, G., Chen, L., Nagineni, S., Alsaaty, S., Harry, A., Logun, C., Pawliczak, R., & Shelhamer, J. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5262 · Cited by 30 · see citing works
The current view on the role of leukotrienes in atherogenesis.
Jawień, J., & Korbut, R. (2010) · PubMed · Cited by 29 · see citing works
A ‘Desaturase Hypothesis’ for Atherosclerosis: Janus-Faced Enzymes in ω–6 and ω–3 Polyunsaturated Fatty Acid Metabolism
Martinelli, N., Consoli, L., & Olivieri, O. (2009) · Lifestyle Genomics · doi:10.1159/000238177 · Cited by 27 · see citing works
5-Lipoxygenase-mediated Endogenous DNA Damage
Jian, W., Lee, S. H., Williams, M. V., & Blair, I. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011841 · Cited by 26 · see citing works
LPS Increases 5-LO Expression on Monocytes via an Activation of Akt-Sp1/NF-κB Pathways
Lee, S. J., Seo, K. W., & Kim, C. D. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2015.19.3.263 · Cited by 25 · see citing works
Quantitation of leukotriene B4 in human sputum as a biomarker using UPLC–MS/MS
Jian, W., Edom, R. W., Xue, X., Huang, M., Fourie, A. M., & Weng, N. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.06.010 · Cited by 24 · see citing works
Ascorbic acid 6-palmitate: a potent inhibitor of human and soybean lipoxygenase-dependent lipid peroxidation
Mohamed, R., Tarannum, S., Manjunath, Y., Kameshwar, V. H., Siddesha, J. M., Angaswamy, N., & Vishwanath, B. S. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12200 · Cited by 24 · see citing works
GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site
Dishart, D., Schnur, N., Klan, N., Werz, O., Steinhilber, D., SAMUELSSON, B., & Rådmark, O. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.11.008 · Cited by 24 · see citing works
The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells
Finkensieper, A., Kieser, S., Bekhite, M. M., Richter, M., Mueller, J. P., Gräbner, R., Figulla, H., Sauer, H., & Wartenberg, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp385 · Cited by 22 · see citing works
Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Listı̀, F., Caruso, M., Incalcaterra, E., Hoffmann, E., Caimi, G., Balistreri, C. R., Vasto, S., Scafidi, V., Caruso, C., & Candore, G. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786264115 · Cited by 21 · see citing works
Products of 5-lipoxygenase and myeloperoxidase activities are increased in young male cigarette smokers
Loke, W. M., Lam, K. M.-J., Chong, W. L., Chew, S. E., Quek, A. M. L., Lim, E. C. H., & Seet, R. C. S. (2012) · Free Radical Research · doi:10.3109/10715762.2012.701291 · Cited by 20 · see citing works
Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk
Merhi, M., Demirdjian, S., Hariri, E. H., Sabbah, N., Youhanna, S. C., Ghassibe‐Sabbagh, M., Naoum, J. J., Haber, M., Othman, R., Kibbani, S., et al. (2015) · Inflammation Research · doi:10.1007/s00011-015-0821-1 · Cited by 20 · see citing works
Metabolism of 5-hydroxy-6,8,11,14-eicosatetraenoic acid by human endothelial cells
Erlemann, K.-R., Cossette, C., Gravel, S., Stamatiou, P. B., Lee, G., Rokach, J., & Powell, W. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.011 · Cited by 20 · see citing works
The effects of oral Cardax™ (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo
Lockwood, S. F., Penn, M. S., Hazen, S. L., Bikádi, Z., & Zsila, F. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.052 · Cited by 19 · see citing works
Synthesis and Antioxidant Activities of Novel Pyrimidine Acrylamides as Inhibitors of Lipoxygenase: Molecular Modeling and In Silico Physicochemical Studies
Saragatsis, M. A., & Pontiki, E. A. (2024) · Molecules · doi:10.3390/molecules29061189 · Cited by 18 · see citing works
Genetic Variants in the Promoter Region of the ALOX5AP Gene and Susceptibility of Ischemic Stroke
Ji, R., Jia, J., Ma, X., Wu, J., Zhang, Y., & Xu, L. (2011) · Cerebrovascular Diseases · doi:10.1159/000330341 · Cited by 17 · see citing works
The putative role of leukotrienes in experimental atherogenesis
Jawień, J. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.620 · Cited by 17 · see citing works
A metabolomics study on effects of polyaromatic compounds in oil sand extracts on the respiratory, hepatic and nervous systems using three human cell lines
Sarma, S. N., Kimpe, L. E., Doyon, V. C., Blais, J. M., & Chan, H. M. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108680 · Cited by 15 · see citing works
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases
Fortunato, G., & Taranto, M. D. D. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.018 · Cited by 15 · see citing works
HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression
Jang, E. J., Baek, S. E., Kim, E., Park, S. Y., & Kim, C. D. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2019.04.001 · Cited by 14 · see citing works
Arachidonic acid is associated with dyslipidemia and cholesterol-related lipoprotein metabolism signatures
Li, F., Wang, Y., Yu, H., Gao, X., Li, L., Sun, H., & Qin, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1075421 · Cited by 14 · see citing works
Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection
Loke, W. M., Chow, A. Y., Sing, K. L. M., Lee, J. C., Halliwell, B. B., Lim, E. C. H., Quek, A. M. L., Ooi, E. E., & Seet, R. C. S. (2013) · Virology Journal · doi:10.1186/1743-422x-10-322 · Cited by 14 · see citing works
5‐Lipoxygenase Gene Variants Are Not Associated With Atherosclerosis or Incident Coronary Heart Disease in the Multi‐Ethnic Study of Atherosclerosis Cohort
Tsai, M. Y., Cao, J., Steffen, B. T., Weir, N. L., Rich, S. S., Liang, S., & Guan, W. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002814 · Cited by 13 · see citing works
Novel Multi-Target Agents Based on the Privileged Structure of 4-Hydroxy-2-quinolinone
Kostopoulou, I., Tzani, A., Chronaki, K., Prousis, K. C., Pontiki, E. A., Hadjipavlou‐Litina, D., & Detsi, A. (2023) · Molecules · doi:10.3390/molecules29010190 · Cited by 12 · see citing works
Myeloid Cell 5-Lipoxygenase Activating Protein Modulates the Response to Vascular Injury
Zhou, Y., Ricciotti, E., Miwa, T., Liu, S., Ihida‐Stansbury, K., Landesberg, G. P., Jones, P. L., Scalia, R. G., Song, W., Assoian, R. K., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.300755 · Cited by 12 · see citing works
5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cells
Lötzer, K., Jahn, S., Krämer, C., Hildner, M., Nüsing, R. M., Funk, C. D., & Habenicht, A. J. R. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.04.005 · Cited by 11 · see citing works
Self-citation
Promoter methylation and functional variants in arachidonate 5‐lipoxygenase and forkhead box protein O1 genes associated with coronary artery disease
Heidari, L., Ghaderian, S. M. H., Vakili, H., & Salmani, T. A. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28501 · Cited by 10 · see citing works
2D-3D Mixed Face Recognition Schemes
Rama, A., Tarrs, F., Rurainsky, J., & Eisert, P. (2008) · InTech eBooks · doi:10.5772/6398 · Cited by 10 · see citing works
Is There a Role for the Macrophage 5‐Lipoxygenase Pathway in Aortic Aneurysm Development in Apolipoprotein E–Deficient Mice?
Funk, C. D., Cao, R. Y., Zhao, L., & Habenicht, A. J. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1383.012 · Cited by 10 · see citing works
Self-citation
Hydrolysis of lipoproteins by sPLA2’s enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2’s IIA, V and X
Pruzanski, W., Kopilov, J., & Kuksis, A. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.12.004 · Cited by 8 · see citing works
The Genetics of Innate Immunity and Inflammation in Ageing, Age-Related Diseases and Longevity
Caruso, C., Balistreri, C. R., Crivello, A., Forte, G. I., Grimaldi, M. P., Listı̀, F., Scola, L., Vasto, S., & Candore, G. (2008) · Springer eBooks · doi:10.1007/978-0-387-76842-7_14 · Cited by 8 · see citing works
BLTR1 in Monocytes Emerges as a Therapeutic Target For Vascular Inflammation With a Subsequent Intimal Hyperplasia in a Murine Wire-Injured Femoral Artery
Baek, S. E., Park, S. Y., Bae, S. S., Kim, K., Lee, W. S., & Kim, C. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01938 · Cited by 7 · see citing works
The role of leukotriene B4 in early stages of experimental paracoccidioidomycosis induced in phenotypically selected mouse strains
Balderramas, H. D. A., Ribeiro, O. G., Soares, Â. M. V. D. C., & de Oliveira, S. L. (2013) · Medical Mycology · doi:10.3109/13693786.2013.777163 · Cited by 7 · see citing works
New fatty acids, oxylipins and volatiles in microalgae
Lang, I. (2007) · doi:10.53846/goediss-243 · Cited by 7 · see citing works
Functional variants of the human 5-lipoxygenase gene and their genetic diagnosis
Geiger, E. V., Doehring, A., Kirchhof, A., & Lötsch, J. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.04.001 · Cited by 6 · see citing works
5-Lipoxygenase in monocytes emerges as a therapeutic target for intimal hyperplasia in a murine wire-injured femoral artery
Baek, S. E., Jang, M. A., Lee, S. J., Park, S. Y., Bae, S. S., & Kim, C. D. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.012 · Cited by 6 · see citing works
Interleukin-1β inhibits synthesis of 5-lipooxygenase in lipopolysaccharide-stimulated equine whole blood
Mangal, D., Uboh, C. E., Jiang, Z., & Soma, L. R. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.01.001 · Cited by 5 · see citing works
The development of methodology for clinical measurement of 5-lipoxygenase pathway intermediates from human peripheral blood mononuclear cells
Willey, M. B., Alborn, W. E., Lutzke, B. S., LeLacheur, R. M., White, R. J., Stavrakis, G., Konrad, R. J., & Ackermann, B. L. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.09.034 · Cited by 5 · see citing works
Leukotriene receptor antagonism with montelukast as a possible therapeutic for venous thromboembolism prophylaxis: An observational study
Sutton, S. S., Magagnoli, J., Cummings, T. H., & Hardin, J. W. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106649 · Cited by 3 · see citing works
Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice
Keever, K., & Askari, B. (2024) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2024.100203 · Cited by 2 · see citing works
ALOX5AP gene variants show differential association with coronary artery disease in different populations
Alwan, A. A., Youhanna, S. C., Platt, D. E., El‐Sibai, M., Yerezian, J. S., Deeb, M. E., Khazen, G., Saadé, S., Zreik, T. G., el Bayeh, H., et al. (2010) · Journal of Community Genetics · doi:10.1007/s12687-010-0015-z · Cited by 2 · see citing works
Genetic analyses of circulating PUFA-derived mediators identifies heritable dihydroxyeicosatrienoic acid species
McGurk, K. A., Farrell, L. N., Kendall, A. C., Keavney, B. D., & Nicolaou, A. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106638 · Cited by 2 · see citing works
Mouse Models of Experimental Atherosclerosis as a Tool for Checking a Putative Anti-Atherogenic Action of Drugs
Jawień, J. (2012) · InTech eBooks · doi:10.5772/26071 · Cited by 2 · see citing works
Analysis of Genetic Variants in the Glucocorticoid Receptor Gene NR3C1 and Stenosis of the Carotid Artery in a Polish Population with Coronary Artery Disease
Gorący, J., Gorący, A., Wójcik-Grzeszczuk, A., Gorący, I., & Rosik, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081912 · Cited by 1 · see citing works
Prostaglandins and Leukotrienes
Lötzer, K., & Habenicht, A. J. R. (2008) · Wiley eBooks · doi:10.1002/9783527626236.ch13
Self-citation
The nuclear factor k[kappa]B signal transduction pathway : Its role in atherogenesis and intimal hyperplasia
Bu, D.-X. (2006) · Figshare
Identification and molecular characterization of a novel splice variant of human 5- lipoxygenase gene
Singh, A. K., Kumar, R. K., Shukla, A. A., Hariprasad, G., Chauhan, S. S., & Dey, S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3732-2
Role of -463G/A Promoter Polymorphism of Myeloperoxidase in the Development of Atherosclerosis
Mäkelä, R. (2009) · Tampere University Institutional Repository (Tampere University)

Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 457 · see citing works
Self-citation
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
Poeckel, D., & Funk, C. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq016 · Cited by 185 · see citing works
Self-citation
Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
Bäck, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058020 · Cited by 66 · see citing works
Advances in Research on the Relationship between 5-Lipoxygenase and Atherosclerosis
Zhang, M. (2009) · Zhongguo bijiao yixue zazhi
The current view on the role of leukotrienes in atherogenesis.
Jawień, J., & Korbut, R. (2010) · PubMed · Cited by 29 · see citing works

Authors: LOTZER, K., FUNK, C., & HABENICHT, A.
Affiliations: Queen's University (CA)
Friedrich Schiller University Jena (DE)
Corresponding author: HABENICHT, A
ORCID: FUNK, C
HABENICHT, A
Venue: Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Publisher: Elsevier BV
Published: 2005-07-21
Volume: 1736
Issue: 1
Pages: 30-7
ISSN: 1388-1981 (ISSN-L)
DOI: 10.1016/j.bbalip.2005.07.001
OpenAlex: W2132989642
Cited by: 108
References: 51
Citations by year: 2024: 2 · 2023: 3 · 2022: 6 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 10
FWCI: 4.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft
National Institutes of Health (2r01hl058464-04)
National Heart, Lung, and Blood Institute (HL 58464)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
Keywords: 5-lipoxygenase, leukotrienes, atherosclerosis, atherogenesis, arterial remodeling, leukotriene B4, cysteinyl leukotrienes, cysteinyl leukotriene receptor, arachidonic acid metabolism, leukocytes, inflammation
MeSH terms: Animals, Arachidonate 5-Lipoxygenase, Arteries, Arteriosclerosis, Signal Transduction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks